Cargando…

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease

Since inflammatory bowel disease (IBD) patients were excluded from vaccine authorization studies, limited knowledge exists regarding perceptions and unfavorable effects of COVID-19 vaccination in this group. We aimed to investigate the real-world use and adverse events (AEs) of COVID-19 vaccines in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orfanoudaki, Eleni, Zacharopoulou, Eirini, Kitsou, Vassiliki, Karmiris, Konstantinos, Theodoropoulou, Angeliki, Mantzaris, Gerassimos J., Tzouvala, Maria, Michopoulos, Spyridon, Zampeli, Evanthia, Michalopoulos, Georgios, Karatzas, Pantelis, Viazis, Nikos, Liatsos, Christos, Bamias, Giorgos, Koutroubakis, Ioannis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836981/ https://www.ncbi.nlm.nih.gov/pubmed/35160092 http://dx.doi.org/10.3390/jcm11030641

Ejemplares similares

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study
por: Mantzaris, Gerassimos J, et al.
Publicado: (2021)

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
por: Bamias, Giorgos, et al.
Publicado: (2021)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Clinical profiles of moderate and severe Crohn’s disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines
por: Mantzaris, Gerassimos J., et al.
Publicado: (2015)

The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
por: Katsoula, Anastasia, et al.
Publicado: (2023)

Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
por: Axiaris, Georgios, et al.
Publicado: (2021)

The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Correction to: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Poor performance of predictive equations to estimate resting energy expenditure in patients with Crohn’s disease
por: Karachaliou, Alexandra, et al.
Publicado: (2023)

Small bowel enteropathy associated with olmesartan medoxomil treatment
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Inflammatory bowel disease: Greek patients’ perspective on quality of life, information on the disease, work productivity and family support
por: Viazis, Nikos, et al.
Publicado: (2013)

Assessment of Dietary Adequacy and Quality in a Sample of Patients with Crohn’s Disease
por: Karachaliou, Alexandra, et al.
Publicado: (2022)

Secondary metastatic lesions to colon and rectum
por: Galanopoulos, Michail, et al.
Publicado: (2018)

DNA Methylation Profile of Genes Involved in Inflammation and Autoimmunity in Inflammatory Bowel Disease
por: Karatzas, Pantelis S., et al.
Publicado: (2014)

Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis
por: Kaltsa, Garyfallia, et al.
Publicado: (2016)

Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2020)

COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract
por: Galanopoulos, Michail, et al.
Publicado: (2020)

Sedation during endoscopic procedures: a Hellenic Society of Gastroenterology Position Statement
por: Viazis, Nikolaos, et al.
Publicado: (2023)

Retroflexion, a costless endoscopic maneuver, increases adenoma detection rate in the ascending colon
por: Michopoulos, Spyridon, et al.
Publicado: (2021)

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study
por: Bressler, Brian, et al.
Publicado: (2021)

Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater
por: Michopoulos, Spyridon, et al.
Publicado: (2016)

Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab
por: Axiaris, Georgios, et al.
Publicado: (2023)

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2023)

Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease
por: Voudoukis, Evangelos, et al.
Publicado: (2016)

Predictors of colorectal cancer screening awareness among people working in a hospital environment
por: Michopoulos, Spyridon, et al.
Publicado: (2017)

Greek results of the “ENERGIB” European study on non-variceal upper gastrointestinal bleeding
por: Papatheodoridis, George, et al.
Publicado: (2012)

Association of TNF and FcγRΙΙΙA gene polymorphisms with differential response to infliximab in a Greek cohort of Crohn’s disease patients
por: Papamichael, Konstantinos, et al.
Publicado: (2011)

Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab
por: Koumaki, Dimitra, et al.
Publicado: (2020)

DNA methylation changes in inflammatory bowel disease
por: Karatzas, Pantelis S., et al.
Publicado: (2014)

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
por: Theodoraki, Eirini, et al.
Publicado: (2021)

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
por: Revés, Joana, et al.
Publicado: (2022)

Psychometric properties of the Post Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) in Greek women after cesarean section
por: Orovou, Eirini, et al.
Publicado: (2021)

Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018)

A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates
por: Viazis, Nikos, et al.
Publicado: (2022)

Oxidative imbalance increases the risk for colonic polyp and colorectal cancer development
por: Tsounis, Dimitrios, et al.
Publicado: (2022)

Translation and Validation of the Greek Version of the Antipsychotics and Sexual Functioning Questionnaire (ASFQ)
por: Angelaki, Maria, et al.
Publicado: (2021)

The ulcerative colitis narrative Greece survey: patients’ and physicians’ perspective on quality of life and disease management
por: Viazis, Nikos, et al.
Publicado: (2022)

Endoscopic intermuscular dissection (EID) of a severely fibrotic benign rectal lesion in an area affected by radiation proctitis
por: Tribonias, George, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tebvu6li52d569es9j06l50cil